/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
MONTREAL, Nov. 6, 2013 /CNW Telbec/ - OPMEDIC GROUP INC. ("OPMEDIC Group") (TSX: OMG) announces the completion of the amalgamation (the "Amalgamation") of OPMEDIC Group and Kemourmedic Acquisition Inc., a wholly-owned subsidiary of Kemourmedic Group Inc., all of the outstanding shares of which are owned by Drs. Pierre St-Michel, Marc Villeneuve and Jean-Yves Fontaine (collectively, the "Founders"), pursuant to which OPMEDIC Group has been taken private.
Pursuant to the Amalgamation that closed earlier today, each shareholder of OPMEDIC Group other than the Founders received one redeemable share of the amalgamated corporation for each common share of OPMEDIC Group held immediately prior to the Amalgamation and each redeemable share was then immediately redeemed for $2.90 payable in cash.
Applications have been filed to delist the common shares of OPMEDIC Group from the Toronto Stock Exchange and to terminate OPMEDIC Group's status as a reporting issuer under applicable Canadian provincial securities laws.
About OPMEDIC Group
OPMEDIC Group is a company incorporated under the laws of the Province of Quebec which provides healthcare-related services including surgical and endoscopic facilities and services to patients and surgeons (with its OPMEDIC division), fertility treatments, medical imaging, laboratory services and diagnostic procedures (with its PROCREA Cliniques division, its subsidiary 8362556 Canada Inc. and a joint venture 7667264 Canada Inc.) and sperm banking services (with its PROCREA Cryopreservation Centre subsidiary).
The content of this press release has not been approved by nor submitted to the TSX which assumes no liability therefor.
SOURCE: OPMEDIC GROUP INC.
For further information:
Vice President Finance and Chief Financial Officer
(514) 345-8535, x 2260